Open access
Aug 2026
A Retrospective, Single-Arm, Observational Study in Patients with Multiple Sclerosis in India Receiving Ocrelizumab Therapy for 1 Year.
BACKGROUND AND OBJECTIVES Ocrelizumab is an established therapy for multiple sclerosis (MS). However, real-world data from Indian clinical settings remain limited. Hence, the present study was conducted to evaluate the clinical effectiveness, radiological response, and safety profile of ocrelizumab over 12 months of th...
M. Srivastava, J. D. Mukherji, Anshu Rohatgi et al.
· Annals of Indian Academy of... · 0 citations